Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Neal

Surgery Pittsburgh, PA Medical Doctor

NPI 1568666840 CMS profile 1389412

200 Lothrop St, F1271.2 Puh Department Of Surgery, Pittsburgh, PA 15213

Open in the dashboard

General payments

$34,068

40 records reported · program years 2019–2025

Research payments

$3,905

Paid to them · 33 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$464,683 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Matthew Neal of Pittsburgh, PA is reported in the CMS Open Payments database as having received $34,068 across 40 general payments and $3,905 in research payments paid to them. Separately, studies naming them as principal investigator received $464,683 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,678 1
2024 General $11,149 3
2023 General $7,608 16
2023 Research $3,905 33
2022 General $22 1
2021 General $3,020 2
2019 General $9,592 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Neal
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Matthew Neal were reported at $2,678. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Matthew Neal Surgery median Middle half National median
2019 $9,592 $253 $82–$1,521 $163
2020 $0 $131 $40–$706 $114
2021 $3,020 $168 $50–$904 $132
2022 $22 $224 $76–$1,218 $149
2023 $7,608 $253 $82–$1,255 $160
2024 $11,149 $279 $90–$1,381 $164
2025 $2,678 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Takeda Pharmaceuticals U.S.A., Inc. $11,006 2 payments
  2. Haemonetics Corporation $8,070 5 payments
  3. Janssen Research & Development, LLC $5,430 7 payments
  4. Octapharma USA, Inc. $4,779 9 payments
  5. CSL Behring $4,162 10 payments
  6. Cerus Corporation $612 5 payments
  7. Intuitive Surgical, Inc. $10 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $13,348 10 payments
  2. Consulting Fee $9,698 4 payments
  3. Honoraria $7,120 2 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $2,500 1 payment
  5. Food and Beverage $1,339 22 payments
  6. Education $64 1 payment
Products named General payments · program years 2019–2025
  1. TEG6s HEMOSTASIS SYSTEM $5,698 3 payments
  2. TEG5000 HEMOSTASIS ANALYZER $5,050 3 payments
  3. FIBRYGA $4,779 9 payments
  4. Kcentra $4,162 10 payments
  5. INTERCEPT BLOOD SYSTEM FOR PLATELETS $612 5 payments
  6. Da Vinci Surgical System $10 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Takeda Pharmaceuticals U.S.A., Inc. $3,905 33 payments

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$70,456

Medicare's payments for the services billed

Medicare patients

234

Average age 71

Services billed

553

101 women, 133 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Ischemic heart disease 45%
Depression 45%
Chronic kidney disease 41%
Diabetes 38%
Heart failure 38%
Atrial fibrillation 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

73 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record